Novo Nordisk A/S
Wegovy could prevent up to 1.5 million heart attacks, strokes over 10 years, study says
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Novo Nordisk’s blockbuster weight loss injection Wegovy could prevent up to 1.5 million heart attacks, strokes and other cardiovascular events in the U.S. over 10 years, according to […]
Read More
UBS says this stock is the ‘best story’ among U.S. large caps, sees more than 15% upside ahead
Eli Lilly has had a great run, but UBS expects about 16% further upside in the coming months as a steady stream of positive news propels the stock higher and revenue growth accelerates. Calling it the “best fundamental story” among U.S. large caps, UBS analyst Colin Bristow on Friday lifted his price target to $612 […]
Read More
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Liselotte Sabroe | Afp | Getty Images Novo Nordisk on Thursday said it will acquire Inversago Pharma, a privately held obesity drug maker, for up to $1.08 billion to broaden the Danish company’s blockbuster weight loss portfolio. The deal is Novo Nordisk’s latest attempt to capitalize on the weight loss industry gold rush, which began […]
Read More
European marketplaces climb on strong earnings ahead of essential U.S. inflation print
Traders will work at the inventory exchange in Frankfurt, Germany. Daniel Roland | Afp | Getty Photographs LONDON — European markets had been larger on Thursday as investors digested a new spherical of corporate earnings and seemed ahead to a important U.S. inflation print that could present hints about the Federal Reserve’s following financial policy […]
Read More
Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar
A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk, which makes the weight-loss drug Wegovy, raised its outlook for 2023 Thursday, as it reported soaring sales. The Danish pharmaceutical company reported a 30% increase […]
Read More
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk‘s obesity drug Wegovy slashed the risk of serious heart problems by 20% in a large clinical trial – a landmark finding that could put more […]
Read More
Obesity drug Wegovy’s landmark trial result could ‘open up’ health insurance access, analyst says
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters LONDON — Popular weight-loss drug Wegovy could be made available under more health insurance schemes, after the results of a late-stage trial pointed to the drug’s efficacy in […]
Read More
Stocks making the biggest moves midday: Beyond Meat, Chegg, PNC Financial, Dish and more
In this article PNC MTB BYND PLTR IFF Follow your favorite stocksCREATE FREE ACCOUNT Getty Images PNC Financial, Citizens Financial, M&T Bank — Regional bank stocks were broadly under pressure on Tuesday after Moody’s downgraded the credit in several smaller institutions. The ratings agency also said some larger banks were under review for a downgrade. […]
Read More
Here’s what is behind the stock market’s selloff and what we’re doing about it
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Stocks sink Eli Lilly surges Palo Alto slumps 1. Stocks sink U.S. stocks tumbled Tuesday after Moody’s downgraded the credit rating on a slew of small and mid-sized banks, sending […]
Read More